Balakrishnan MP, Cilenti L, Mashak Z, Popat P, Alnemri ES, Zervos AS. THAP5 is a human cardiac-specific inhibitor of cell cycle that is cleaved by the proapoptotic Omi/HtrA2 protease during cell death. Am J Physiol Heart Circ Physiol 297: H643-H653, 2009. First published June 5, 2009 doi:10.1152/ajpheart.00234.2009.-Omi/ HtrA2 is a mitochondrial serine protease that has a dual function: while confined in the mitochondria, it promotes cell survival, but when released into the cytoplasm, it participates in caspase-dependent as well as caspase-independent cell death. To investigate the mechanism of Omi/HtrA2's function, we set out to isolate and characterize novel substrates for this protease. We have identified Thanatosassociated protein 5 (THAP5) as a specific interactor and substrate of Omi/HtrA2 in cells undergoing apoptosis. This protein is an uncharacterized member of the THAP family of proteins. THAP5 has a unique pattern of expression and is found predominantly in the human heart, although a very low expression is also seen in the human brain and muscle. THAP5 protein is localized in the nucleus and, when ectopically expressed, induces cell cycle arrest. During apoptosis, THAP5 protein is degraded, and this process can be blocked using a specific Omi/HtrA2 inhibitor, leading to reduced cell death. In patients with coronary artery disease, THAP5 protein levels substantially decrease in the myocardial infarction area, suggesting a potential role of this protein in human heart disease. This work identifies human THAP5 as a cardiac-specific nuclear protein that controls cell cycle progression. Furthermore, during apoptosis, THAP5 is cleaved and removed by the proapoptotic Omi/HtrA2 protease. Taken together, we provide evidence to support that THAP5 and its regulation by Omi/ HtrA2 provide a new link between cell cycle control and apoptosis in cardiomyocytes.Omi/HtrA2; Thanatos-associated protein 5; coronary artery disease; apoptosis OMI/HTRA2 IS A MITOCHONDRIAL serine protease that has an essential role in both mitochondrial homeostasis, as well as cell death (49). Most of the studies on Omi/HtrA2 have substantially contributed to our understanding of the mechanism of its proapoptotic function. On the contrary, very little is known about its normal function within the mitochondria. Upon induction of apoptosis, Omi/HtrA2 is released to the cytoplasm, where it participates in caspase-dependent and caspase-independent cell death (21,34,45,48,50). The mechanism of its proapoptotic activity involves degradation of specific substrates that include mitochondrial protein HS1-associated protein X-1, cytoplasmic proteins X-chromosome-linked inhibitor, PEA/PED, and Apollon/Bruce (10,41,44,47,51), as well as nuclear factors WARTS, and p73 (28,29,31,33). The protease activity of Omi/HtrA2 is always necessary and essential for its proapoptotic function. We have used the yeast two-hybrid system to isolate and characterize new Omi/HtrA2 interacting proteins (10). These interacting proteins could be new substrates of Omi/HtrA...